This follow-up report is submitted, to fda in accord with applicable regulations.And as indicated, by terumo cardiovascular systems in the initial report submitted to the fda on may 26, 2021.Upon further investigation of the reported event.The following information is new and/or changed: d4: (additional device information, added exp date).G3: (date received by manufacturer).G6: (indication that this is a follow-up report).H2: (follow-up, due to additional information and device evaluation).H3: (device evaluated by manufacturer).H4: (device manufacture date).H6: (identification of evaluation codes 10, 3331, 4245, 4308).Type of investigation #1:10, testing of actual/suspected device.Type of investigation #2: 3331, analysis of production records.Investigation findings: 4245, packaging contains incorrect device.Investigation conclusions: 4308, cause traced to transport/storage.The investigation verified, that incorrect product was shipped.And the root cause for this incident was a picking error.Awareness training was conducted with the shipping staff at the distribution center.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|